|
MTERFD2 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.62440002852094E-09 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.06819999999786E-05 |
| Normal-vs-Stage2 |
2.399000E-03 |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
1.226100E-02 |
| Stage1-vs-Stage2 |
3.858000E-01 |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
8.700000E-01 |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
5.791200E-01 |
| Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.26210000006566E-07 |
| Normal-vs-AfricanAmerican |
2.929800E-01 |
| Normal-vs-Asian |
4.18520000000644E-05 |
| Caucasian-vs-AfricanAmerican |
1.990370E-01 |
| Caucasian-vs-Asian |
7.059000E-01 |
| AfricanAmerican-vs-Asian |
4.565800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.626530E-04 |
| Normal-vs-Female |
2.06869999996862E-06 |
| Male-vs-Female |
2.909600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.199100E-03 |
| Normal-vs-Extreme_Weight |
1.632730E-04 |
| Normal-vs-Obese |
7.763300E-03 |
| Normal-vs-Extreme_Obese |
N/A |
| Normal_Weight-vs-Extreme_Weight |
9.700600E-01 |
| Normal_Weight-vs-Obese |
8.159200E-01 |
| Normal_Weight-vs-Extreme_Obese |
N/A |
| Extreme_Weight-vs-Obese |
7.596600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
N/A |
| Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.443400E-04 |
| Normal-vs-Age(41-60Yrs) |
2.037900E-03 |
| Normal-vs-Age(61-80Yrs) |
1.42260000002281E-06 |
| Normal-vs-Age(81-100Yrs) |
4.969800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.245800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.885400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.012800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.263400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.589600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.208400E-01 |
|
|
CHOL : Cholangiocarcinoma
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
N/A |
| Normal-vs-Grade 2 |
5.312000E-01 |
| Normal-vs-Grade 3 |
5.741600E-01 |
| Normal-vs-Grade 4 |
1.000000E+00 |
| Grade 1-vs-Grade 2 |
N/A |
| Grade 1-vs-Grade 3 |
N/A |
| Grade 1-vs-Grade 4 |
N/A |
| Grade 2-vs-Grade 3 |
7.482400E-01 |
| Grade 2-vs-Grade 4 |
5.312000E-01 |
| Grade 3-vs-Grade 4 |
5.741600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.57889999996552E-06 |
| Normal-vs-N1 |
1.901660E-02 |
| N0-vs-N1 |
5.863600E-01 |
|
|
